Table 1.
Participant characteristics
| Parameter | BC (n = 16) | Control (n = 16) | p value |
|---|---|---|---|
| Age, years | 56 (10) | 56 (10) | .95 |
| Weight, kg | 75.6 (12.0) | 74.9 (11.7) | .87 |
| Body mass index, kg/m2 | 29.0 (3.6) | 27.9 (4.9) | .47 |
| Self‐reported exercise, minutes/week | 225 (275) | 313 (208) | .16a |
| Hemoglobin, g/L | 133 (11) | 134 (8) | .67 |
| Hematocrit, % | 40 (3) | 41 (2) | .51 |
| Cardiovascular risk factors, % | |||
| Sedentary | 25 | 13 | .65 |
| Hypertension | 13 | 0 | .48 |
| Hypercholesterolemia | 0 | 13 | .48 |
| Former smoker | 44 | 50 | .72 |
| Current smoker | 0 | 0 | — |
| Diabetes | 0 | 0 | — |
| Overweight | 31 | 50 | .47 |
| Obese | 44 | 44 | 1 |
| Other comorbid conditions, % | |||
| Arthritis | 31 | 44 | .72 |
| Osteoporosis | 13 | 6 | 1 |
| Thyroid disorder | 13 | 19 | 1 |
| Lung disease | 0 | 0 | 1 |
| Breast cancer characteristics | |||
| Stage II/III/IV, n | 8/7/1 | — | — |
| Epirubicin/doxorubicin, n | 15/1 | — | — |
| Dose, mg/m2 | 307 (75) | — | — |
| Does reduction, n | 3 | — | — |
| No surgery/lumpectomy/mastectomy, n | 1/6/9 | — | — |
| Radiation therapy, n | 15 | — | — |
| Hormone therapy, n | 11 | — | — |
Results are presented as mean (SD).
Abbreviations: —, not applicable; BC, breast cancer.
a
Nonparametric distribute, Mann‐Whitney U/ test used.